ELIOS achieved statistically significant, clinically meaningful IOP lowering, meeting both co-primary endpoints for responder ...

Bausch + Lomb (NYSE:BLCO) highlighted two glaucoma programs during a Wells Fargo-hosted “2026 MedTech Innovation Spotlight” ...

CHERRY HILL, N.J. (WPVI) -- A new procedure is helping to preserve vision for some people with glaucoma. Glaucoma is a silent thief, affecting 3 million Americans, slowly robbing them of their sight.

An Oklahoma City surgeon with the Dean McGee Eye institute developed a procedure for Glaucoma surgery that's being used at hospitals around the globe. Dean McGee Clinical Professor Mahmoud A. Khaimi ...

Shares of Bausch + Lomb rose in premarket trading Monday after the company said that data from its glaucoma procedure trials was positive. Shares in New York traded 5% higher ahead of the morning bell ...

In a pivotal clinical trial, an excimer laser procedure reduced IOP in patients with glaucoma, according to a press release ...

CHICAGO, Illinois — A large retrospective analysis of more than 150,000 eyes from a national eye registry have shown that combining surgeries for glaucoma and cataract into one procedure didn't ...

Glaucoma is a disease of the optic nerve that can lead to vision loss and permanent blindness. Without proper treatment, a person with glaucoma loses peripheral vision first, followed by the loss of ...

India’s minimally invasive glaucoma surgery market is set for steady growth through 2033, driven by rising glaucoma cases, expanding eye care access.

Please provide your email address to receive an email when new articles are posted on . I was honored to give the Stephen A. Obstbaum, MD, Lecture at the 2022 American Society of Cataract and ...

People who undergo incisional surgery for glaucoma and live in areas with elevated levels of oxidative air pollution may be more likely to have the procedure fail than patients who live in areas with ...